AI entity
All 1 tracked stories fall under one category: regulation. Insulet Corporation is most often covered alongside ADMA Biologics, Inc., which appears in 1 of these 1 story. Each story carries 4 original sources on average, compared with 2.7 for the broader beat in this window.
Last mentioned: Jul 12, 2026
Entity pulse
Coverage balance Negative coverage leads. Negative coverage exceeds positive coverage by 100 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
All 1 tracked stories fall under one category: regulation. Insulet Corporation is most often covered alongside ADMA Biologics, Inc., which appears in 1 of these 1 story. Each story carries 4 original sources on average, compared with 2.7 for the broader beat in this window. Their average consequence score of 7 sits level with the 7 recorded across the beat in that window. We currently track 1 AI story that mention Insulet Corporation, all published on July 12, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 28 AI stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Insulet Corporation. Shared-story counts are live from our verified record — not editorial picks.
The AI sector’s poster child, Microsoft Copilot, is at the center of a securities fraud lawsuit for allegedly concealing functionality issues that hurt Azure growth and investor returns.
Insulet Corporation is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
